dna Archives -

Oligonucleotide Therapeutics and Delivery

Oligonucleotide Therapeutics and Delivery Conference

https://pharmaphorum.com/events/oligonucleotide-therapeutics-and-delivery-conference/

News/ News/ R&D/ Top stories

Allergan bolsters aesthetics pipeline with Exicure hair loss deal

Phil Taylor Allergan, alopecia, dna, Exicure, rna 0 Comment

Allergan hasn’t pressed pause on business development in the build-up to its $63 billion buyout by AbbVie, and

Allergan bolsters aesthetics pipeline with Exicure hair loss deal

https://pharmaphorum.com/news/allergan-bolsters-aesthetics-unit-with-exicure-hair-loss-deal/

Banner_Liquid_Biopsy_Lisbon_February_2020

Events/ Events/ Oncology

Liquid Biopsy Summit 2020

diogo.ribeiro@epmgroup.org Biomarkers, dna, genomics, liquid biopsy 0 Comment

The Liquid Biopsy Summit 2020

Liquid Biopsy Summit 2020

https://pharmaphorum.com/events/liquid-biopsy-summit-2020/

Deep Dive/ Digital/ Views & Analysis/ Views and analysis

Developing with start-up DNA

mike.hammerton@pharmaphorum.com Andre Heeg, Deep Dive: Access and Commercialisation, dna, Sandoz, start-up 0 Comment

As head of digital at Sandoz, Andre Heeg is at the forefront of transformation both within his company

Developing with start-up DNA

https://pharmaphorum.com/digital/developing-with-start-up-dna/

Events/ Events/ Partner Content

SMi’s 10th Annual RNA Therapeutics Returns this February 2019

Pavan Solanki dna, gene therapy, rna, rna therapeutics 0 Comment

RNA Therapeutics 2019

SMi’s 10th Annual RNA Therapeutics Returns this February 2019

https://pharmaphorum.com/events/smis-10th-annual-rna-therapeutics-returns-this-february-2019/

Partner content/ Partner Content/ Press releases

The 10th Annual RNA Therapeutics Returns to London this Feb!

Pavan Solanki dna, gene editing, gene therapy, rna, rna therapeutics 0 Comment

RNA Therapeutics

The 10th Annual RNA Therapeutics Returns to London this Feb!

https://pharmaphorum.com/partner-content/the-10th-annual-rna-therapeutics-returns-to-london-this-feb/

GlaxoSmithKline/ News/ News/ R&D/ Top pharmaceutical companies/ Top stories

GSK signs $300m R&D deal with 23andMe

Piotr Wnuk dna, genetic testing, GlaxoSmithKline 0 Comment

GlaxoSmithKline signed a $300 million research and development deal with mail gene profiling company 23andMe, gaining access to

GSK signs $300m R&D deal with 23andMe

https://pharmaphorum.com/r-d/gsk-welcomes-23andmes-dna-database/

Partner Content/ Partner content/ Press releases/ R&D/ R&D

Explore the latest developments in ATMPs at Cell & Gene Therapy 2018

Pavan Solanki cell therapy, dna, gene editing, genetic, genomics 0 Comment

Cell and Gene Therapy 2018

Explore the latest developments in ATMPs at Cell & Gene Therapy 2018

https://pharmaphorum.com/partner-content/explore-the-latest-developments-in-atmps-at-cell-gene-therapy-2018-2/

Oncology/ Partner content/ Partner Content/ Press releases/ R&D

Attendee List Released for SMi’s 9th Annual RNA Therapeutics

Pavan Solanki cancer, dna, exosomes, MHRA, rna 0 Comment

RNA Therapeutics

Attendee List Released for SMi’s 9th Annual RNA Therapeutics

https://pharmaphorum.com/partner-content-oncology/attendee-list-released-for-smis-9th-annual-rna-therapeutics/

Trending

dna

Login